TABLE 1.
Summary of mutant envelope glycoproteins and viruses
| Envelope glycoprotein | Cell-cell fusion activitya | Tm of gp41 six-helix bundle (°C)a,b | Viral infectivityc | gp120 per viriond (arbitrary units) |
|---|---|---|---|---|
| Wild type | +++ | 70 | 4,500 | 0.15 |
| L556A | ± | 64 | 330 | 0.13 |
| L565A | ± | 50 | 120 | 0.20 |
| V570A | ± | 56 | 15 | 0.16 |
| Q551A | +++ | 74 | 2,500 | 0.16 |
| Q563A | +++ | 68 | 21,000 | 0.27 |
The results are from reference 31.
The melting temperature (Tm) of the gp41 six-helix bundle was determined in the N34(L6)C28 model (29).
p24 was determined by antigen capture enzyme-linked immunosorbent assay (Beckman Coulter, Inc.). Nominal viral infectivity (number of foci per nanogram of p24) was calculated by using a dilution of virus that produced 100 foci in a 96-well U87-CD4-CXCR4 cell microculture assay.
The relative amount of gp120 per virion was estimated by Western blot analysis of centrifugally purified virions (51). gp120 was determined with the deglycosylated 55-kDa polypeptide of gp120 (31) and the anti-gp120 MAb Chessie 12 (1). Virion core protein p17 was assessed using immunoglobulin from HIV-infected persons (HIVIG). Antibody binding was visualized by ECL-Plus (Amersham Pharmacia Biotech), and fluorescence was quantitated using a Fuji FLA-3000G analyzer. The ratio of fluorescence intensities is shown.